Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study - Wikidata - awgldk - TriplyDB

Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study

Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study

http://www.wikidata.org/entity/Q28271581

about

Fermented Foods: Are They Tasty Medicines for Helicobacter pylori Associated Peptic Ulcer and Gastric Cancer?Treatment of Helicobacter pylori infection: Current and future insights High antibiotic resistance rate: A difficult issue for Helicobacter pylori eradication treatment Are probiotics useful in Helicobacter pylori eradication?Helicobacter pylori in humans: Where are we now?Safety and acceptability of Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 in Bangladeshi infants: a phase I randomized clinical trial The human microbiome and probiotics: implications for pediatrics The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis Probiotic and technological properties of Lactobacillus spp. strains from the human stomach in the search for potential candidates against gastric microbial dysbiosis Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis Significant Reduction in Helicobacter pylori Load in Humans with Non-viable Lactobacillus reuteri DSM17648: A Pilot Study.A highly acid-resistant novel strain of Lactobacillus johnsonii No. 1088 has antibacterial activity, including that against Helicobacter pylori, and inhibits gastrin-mediated acid production in mice.Improved Helicobacter pylori Eradication Rate of Tailored Triple Therapy by Adding Lactobacillus delbrueckii and Streptococcus thermophilus in Northeast Region of Thailand: A Prospective Randomized Controlled Clinical Trial.Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy.Helicobacter pylori Eradication Therapy: Current Availabilities.Helicobacter pylori eradication: sequential therapy and Lactobacillus reuteri supplementation.Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection Dietary and socio-economic factors in relation to Helicobacter pylori re-infection.Non-viable Lactobacillus reuteri DSMZ 17648 (Pylopass™) as a new approach to Helicobacter pylori control in humans How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial.Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics.Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents Alternative therapies for Helicobacter pylori: probiotics and phytomedicine.A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics.Emerging Role of Probiotics in the Management of Helicobacter pylori Infection: Histopathologic Perspectives.Impact of Age, Gender, and Addition of Probiotics on Treatment Success for Helicobacter pylori in Children.Probiotics as an adjuvant treatment in Helicobacter pylori eradication therapy.Antiproliferative and proapoptotic effects of viable or heat-killed Lactobacillus paracasei IMPC2.1 and Lactobacillus rhamnosus GG in HGC-27 gastric and DLD-1 colon cell lines.Effects of Lactobacillus rhamnosus GG on proliferation and polyamine metabolism in HGC-27 human gastric and DLD-1 colonic cancer cell lines.Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.In Vitro Antimicrobial Activity and Downregulation of Virulence Gene Expression on Helicobacter pylori by Reuterin.Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis.Role of Lactobacillus reuteri in Human Health and Diseases.Improvement of gastrointestinal health status in subjects consuming Lactobacillus reuteri NCIMB 30242 capsules: a post-hoc analysis of a randomized controlled trial A Review on Some Chemical Engineering and Microbiological Aspects Considered in the Production of Highly Concentrated Probiotic Cultures and Bacteriocins by Lactococci and Lactobacilli

P2860

Q26738441-06C417C9-184B-43D7-A5FE-4F1F6213F2B2 Q26769707-34DECB28-B61B-47DC-8C57-E768236AF38A Q26771197-3F6E01DC-8704-4D70-BCF2-DBC603C0F7B2 Q26784386-29C5D2BB-0974-4638-91B7-AFE0D45E54B4 Q26825856-BF1441D2-2957-45A6-A59D-BFF3C542AB29 Q28601612-B7326CF3-B38B-472A-B68D-49D2596A6E43 Q28750959-55AE0624-846C-4734-86E8-738E9344C7E6 Q34443924-343329EE-62B7-4500-8AE9-6D078256771A Q34955025-B8652A7C-FD2E-4591-BFBD-C44C6E479FB3 Q35375748-680A5CC1-7F6C-4998-82DF-AFAC6ACB2BF1 Q35496024-95A0B466-FC5B-4B41-B2A8-AFF9F88D70D5 Q35577427-E0368404-0EFA-4CF9-BE6B-FDAB02143997 Q35763686-78BF5C94-C7C3-415F-B384-C27E3B8BBECE Q36011539-AC473DD9-59AB-4383-BC31-C9F6711201E8 Q36148148-98D593E1-9F41-4449-9468-2041573EDC0C Q36410382-7CA178E2-06E0-444D-B067-AC01DAE00F0E Q36410419-FC54EDA1-2D16-4493-B65D-A65AFD8F5113 Q37127152-FD2CCF35-88E6-4BB6-AB53-D5BA10F057F8 Q37177403-19DB347D-AD6E-4344-8178-C1760A7CD761 Q37378899-1B86D1EE-754E-4BE4-9AF9-6E67CEFC89A0 Q37410679-563ABFBB-996F-4858-8E47-3B426CFBD6C6 Q37682514-1E5CF33D-CDCE-4109-A642-B2B63912DDF1 Q37712802-44BE7B16-C803-4AE4-BC56-EEFE15AE9121 Q37955181-7FEB4F88-0C83-47A0-9582-C654622916CE Q37994645-2F22F021-7E38-43DE-ABFD-C67A1C4AA6F9 Q38495648-F38803D3-74A5-4B2B-A3C9-7473171D21EE Q38875498-A7012939-A179-468A-A243-00F8DA41F477 Q39179173-60DB7F60-7F56-44E3-969C-2FCF49613E13 Q39260465-6D916C38-09E9-42FD-9E42-D0EE5164B35D Q39880897-46E8D574-D81C-4ED5-9BB6-78DD8B02C1D6 Q46236620-C982807C-C30C-4428-856A-1079449F9117 Q47441217-41881016-F8EF-49A4-B260-54A479A5A7FD Q47650511-51307A66-21FA-40C7-A35C-E2D9A864F078 Q55035868-B3723ED5-3948-4522-A5B7-888D33D07A5D Q57155090-82CFE1C6-81BE-45EF-BDDF-165405050F9A Q58692702-8558E11F-6032-462C-9DB3-40DA133F1FD8

P2860

Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study

http://www.wikidata.org/entity/Q28271581

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Inhibition of Helicobacter pyl ...... ication therapy: a pilot study

@ast

Inhibition of Helicobacter pyl ...... ication therapy: a pilot study

@en

Inhibition of Helicobacter pyl ...... ication therapy: a pilot study

@nl

type

label

Inhibition of Helicobacter pyl ...... ication therapy: a pilot study

@ast

Inhibition of Helicobacter pyl ...... ication therapy: a pilot study

@en

Inhibition of Helicobacter pyl ...... ication therapy: a pilot study

@nl

prefLabel

Inhibition of Helicobacter pyl ...... ication therapy: a pilot study

@ast

Inhibition of Helicobacter pyl ...... ication therapy: a pilot study

@en

Inhibition of Helicobacter pyl ...... ication therapy: a pilot study

@nl

P1433

Q28271581-BF38BE92-A8DD-4320-A4BD-E795D9B50431

P1476

Q28271581-93ADB54F-006C-402F-A20D-713A14D4820F

P2093

Q28271581-0E7530DA-5EE7-4224-8979-86A01D394EF2

Q28271581-113CC642-569D-4482-BE89-FD32F14C6BF5

Q28271581-19E30F48-C17C-4A91-80B8-770304237247

Q28271581-1D6DB416-F05E-4418-BD33-9779C87FA420

Q28271581-41B6F71A-ED50-479B-A14C-E1CD8A17B438

Q28271581-44F34C2B-0EE4-46AA-89E0-492F9CCF7E51

Q28271581-57A69CBF-622C-4AF4-8466-C0346EF0C47A

Q28271581-5DD7B358-EC62-4369-AA25-17AAF1BF95A5

Q28271581-5ED6C17D-B0AB-4B5C-AAC8-A2E3F3E16163

Q28271581-75D4C4A0-8CE2-428D-9434-73B6E501DDCA

P2860

Q28271581-00F8BE63-8687-462A-9FFE-ED482238D415

Q28271581-1255BB10-095C-42A2-BD2D-55A6EBAA5C75

Q28271581-1766B2ED-5DE9-4895-A973-05D60D6F94CD

Q28271581-26AE09DA-C6AB-4381-A4D6-FF91AADF26DF

Q28271581-27FC156A-1CED-4F3A-8B8A-857EAAD35869

Q28271581-2B06B0F8-DFC2-4B21-A2EE-C8A98FB479DF

Q28271581-2C86AB6F-2B26-4D3F-809A-875979C066A1

Q28271581-37634A3A-2203-4AA9-8332-0D651BCB8D4F

Q28271581-3DEB4DBE-C97B-40FC-8BC7-10D7A1F6E59A

Q28271581-493B9539-A360-4010-9328-1B22DD1B69FA

P304

Q28271581-994849A5-AF86-48F2-8BC7-2B97006408D2

P31

Q28271581-C129665B-8FA7-4C21-B49B-F7E15801B5C8

P3181

Q28271581-63E8FC57-0DC2-4FF7-B4BA-07822C0232EA

P356

Q28271581-34CD84A0-1ED9-437C-B662-365280D881DC

P407

Q28271581-E4274D3E-A371-47B0-B209-3D8F87E12463

P433

Q28271581-442E4E37-94B0-4A2E-A611-64107E5D4EC1

P478

Q28271581-EC9AF374-7B81-4A14-8EBB-68D2C6E7E586

P577

Q28271581-410C720C-ABCF-4F0C-90D2-97EB0F330953

P5875

Q28271581-CF77C525-CD34-4EEB-966A-9A10AA3EA420

P698

Q28271581-F9AD5E41-7BBD-4695-BEE6-FE61416890CE

P921

Q28271581-0574901F-2BAE-41C8-9494-C16E4CD0B5AE

Q28271581-1AD4AB73-9AB9-4AB9-A440-3AB980D6860E

P3181

P356

J.1523-5378.2008.00593.X

P1433

P1476

Inhibition of Helicobacter pyl ...... ication therapy: a pilot study

@en

P2093

Angela De Canio

http://www.w3.org/2001/XMLSchema#string

Anna Maria Magistà

http://www.w3.org/2001/XMLSchema#string

Elena Lionetti

http://www.w3.org/2001/XMLSchema#string

Enzo Ierardi

http://www.w3.org/2001/XMLSchema#string

Flavia Indrio

http://www.w3.org/2001/XMLSchema#string

Giovanni Maurogiovanni

http://www.w3.org/2001/XMLSchema#string

Luciano Cavallo

http://www.w3.org/2001/XMLSchema#string

Nunzia Bucci

http://www.w3.org/2001/XMLSchema#string

Ruggiero Francavilla

http://www.w3.org/2001/XMLSchema#string

Stefania Paola Castellaneta

http://www.w3.org/2001/XMLSchema#string

P2860

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects

Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis

Helicobacter pylori infection and the development of gastric cancer

Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis.

Accurate diagnosis of Helicobacter pylori. 13C-urea breath test.

Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract.

Simplified single sample 13Carbon urea breath test for Helicobacter pylori: comparison with histology, culture, and ELISA serology

Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects

Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial.

P304

127-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4414759

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/J.1523-5378.2008.00593.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5531644

http://www.w3.org/2001/XMLSchema#string

P698

18321302

http://www.w3.org/2001/XMLSchema#string

P921

eradication of infectious diseases

Helicobacter pylori